# Findings Report — Prompt 5: Ryman Healthcare Latest

**Run Date:** 8 June 2026, 03:00 NZST
**Prompt:** #5 — Ryman Healthcare Latest (Provider Watch)
**Category:** Provider Watch — 11_Market_and_Industry_Reports

---

## What Was Searched

1. `Ryman Healthcare NZX announcement July 2026` — NZX announcements page
2. `Ryman Healthcare investor presentation half year 2026` — latest presentations
3. `Ryman Healthcare annual report 2026 site:rymanhealthcare.co.nz` — company website
4. `Ryman Healthcare FY26 results reaction news June 2026` — media and analyst reaction
5. `"RYM" "Ryman" "retail bond" June 2026 prospectus` — bond market activity
6. NZX RYM announcements page extracted for full chronology

---

## What Was Found

### 1. FY26 Annual Report — Published 5 June 2026 ✅ Already in KB

The FY26 Annual Report (year ended 31 March 2026) was published 5 June 2026. The KB already holds:

- `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - FY26 Annual Report.pdf`
- `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - FY26 Annual Report.txt`
- `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - Source Brief - FY26 Annual Report.md`

The source brief comprehensively captures the financial results, strategy, and commentary.

### 2. FY26 Results Media Release — 26 May 2026

Media release _"FY26 marks significant year of progress"_ by CEO Naomi James:

- **Operating revenue** up 10% to **$849M**
- **Operating EBITDAF** up 94% to **$88M** (nearly doubled)
- **First positive free cash flow in a decade: $188M**
- **PBTF loss** reduced from -$385M to **-$73M**
- **Gearing at sector-low 27.8%** — balance sheet reset complete
- No bank maturities until FY31; >75% of drawn debt on fixed rates
- New capital management framework with pathway to **return to dividends in FY28**

**Sources:**

- https://www.rymanhealthcare.co.nz/investor-news/fy26-marks-significant-year-of-progress (accessed 8 Jun 2026)
- https://www.nzx.com/announcements/473286 (accessed 8 Jun 2026)

### 3. Retail Bond Offer — 3 June 2026 ⚠️ NEW — NOT IN KB

Ryman announced it is **considering a 6-year fixed rate secured bond offer** to replace its $150M RYM010 retail bond maturing December 2026. The offer would be to institutional and retail NZ investors. Full details expected week beginning 8 June 2026. RYM010 bondholders may be able to exchange existing bonds for new ones.

- Arranger: ANZ Bank New Zealand
- Joint Lead Managers: Craigs Investment Partners, Forsyth Barr, Westpac
- Bonds expected to be quoted on NZX Debt Market
- Trading in RYM010 bonds to be suspended during transition

**Source:** https://www.nzx.com/announcements/473748 (accessed 8 Jun 2026)
**Status:** This is market-sensitive — the offer is opening this week (w/c 8 June 2026)

### 4. New Independent Director Appointed — 24 April 2026

**Hamish Rumbold** appointed as independent non-executive director from 1 May 2026.

- Currently a director of House of Travel, Orbit Remit, LIC, and The Warehouse Group
- Former Chief Digital and Technology Officer at Kiwibank
- Brings digital, data, and technology governance expertise
- This appointment **completes the Board refresh** (per Chair Dean Hamilton)
- Will stand for re-election at 2026 AGM

**Source:** https://www.nzx.com/announcements/471447 (accessed 8 Jun 2026)

### 5. Q4 FY26 Trading Update — 15 April 2026

- **Total ORA sales:** 1,410 for FY26 (in line with 1,300–1,400 guidance)
- New DMF of **30% now widely accepted** — net sales applications exceeding turnover levels for first time since contract change (late 2024)
- **Mature care centre occupancy:** 96.1% (consistent with prior quarter)
- **4 of 5 care centres opened in past 2 years** now above **80% occupancy**
- **Active construction sites reduced** from 7 to just **2**
- **Free cash flow estimated ~$180M** (actual delivered: $188M)
- **Net interest-bearing debt:** $1.57B (31 Mar 2026)
- Relocations from Margaret Stoddart and Woodcote care centre closures (39 residents)

**Source:** https://www.nzx.com/announcements/470907 (accessed 8 Jun 2026)

### 6. Analyst Reaction — Macquarie Outperform

- Macquarie reaffirmed **Outperform** rating following FY26 results
- Care division described as a **"standout performer"** expected to drive FY27 upside
- Macquarie noted cash release potential **exceeds $500M target** for FY29
- RYM.NZ share price ranged NZ$2.17–$2.27 on results day

**Source:** https://www.investing.com/news/stock-market-news/why-is-ryman-healthcare-stock-gaining-today-93CH-4710236 (accessed 8 Jun 2026)

### 7. Upcoming Key Dates

| Date                   | Event                                       |
| ---------------------- | ------------------------------------------- |
| 8 Jun 2026 (this week) | Retail bond offer details expected          |
| 28 Jul 2026            | **2026 Annual Shareholders Meeting**        |
| 4 Jun 2026             | Director nominations closing date announced |
| By 31 Jul 2026         | Climate-related disclosures to be published |

### 8. Investor Day (3 Feb 2026) — Refreshed Strategy

Key strategic direction already captured in the source brief. Notable additional detail:

- **Australia favoured for greenfield investment**; NZ for brownfield expansion
- **Land bank review completed** — 6 sites retained for potential development
- **Dividend payout policy:** 20–50% of CFEO per share, targeting FY28 return
- **Aged care EBITDAF per bed target:** $25–30k by FY29

**Source:** https://www.rymanhealthcare.co.nz/investor-news/refreshed-strategy-and-new-capital-management-framework (accessed 8 Jun 2026)

---

## Value Assessment 🟠 HIGH

Several newsworthy developments that warrant KB updates:

1. **Retail bond offer (3 Jun 2026)** — market-sensitive; not yet in KB. The offer details are due this week. High value because it signals Ryman's capital management strategy and refinancing approach.
2. **Board refresh complete** with Hamish Rumbold appointment — governance update not fully captured in source brief.
3. **Q4 trading update** details on DMF acceptance, care occupancy, and construction pipeline reduction — operational milestones that track the strategy reset.
4. **Analyst endorsement** (Macquarie Outperform) — external validation of the turnaround.

---

## KB ACTION

### Files to Create/Update:

1. **UPDATE** `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - Source Brief - FY26 Annual Report.md`
   - Add section 9: "Post-Annual Report Developments" covering:
     - Retail bond offer (3 Jun 2026)
     - Hamish Rumbold appointment / board refresh completion
     - AGM date (28 Jul 2026)
     - Analyst reaction (Macquarie Outperform)

2. **CREATE** `01_Knowledge_Base/11_Market_and_Industry_Reports/2026-06-08 Ryman Healthcare - Post-FY26 Developments.md`
   - Standalone note covering the bond offer, director appointment, Q4 trading update details not in annual report, and key upcoming dates.

### Alternative (simpler):

- PATCH the existing source brief to add a "Post-FY26 Developments" section at the end with the bond offer, director appointment, and AGM date.

---

## Cross-References

- Existing KB file: `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - Source Brief - FY26 Annual Report.md`
- Existing KB file: `11_Market_and_Industry_Reports/2026 - Ryman Healthcare - FY26 Annual Report.pdf`
- Related prompt: Prompt 6 (Summerset), Prompt 7 (Oceania) — provider watch series

---

_Report generated automatically by Hermes Agent research cron job, 8 June 2026._
